Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 7, Pages 4145-4160
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-12-27
DOI
10.1074/jbc.m113.521062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity
- (2013) Debapriya Dutta et al. Autophagy
- Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage
- (2013) Mirko Völkers et al. CIRCULATION
- Role of microangiopathy in diabetic cardiomyopathy
- (2013) Adriana Adameova et al. HEART FAILURE REVIEWS
- Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy
- (2013) K. Maiellaro-Rafferty et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice
- (2013) Andrea Stöhr et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics
- (2013) M. A. Schroeder et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetic cardiomyopathy: Myth or reality?
- (2012) Laura Ernande et al. Archives of Cardiovascular Diseases
- Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts
- (2012) Saisudha Koka et al. BASIC RESEARCH IN CARDIOLOGY
- Carbonic anhydrase II promotes cardiomyocyte hypertrophy
- (2012) Brittany F. Brown et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Mammalian target of rapamycin signaling in diabetic cardiovascular disease
- (2012) Zhao Chong et al. Cardiovascular Diabetology
- Myocardial insulin resistance, metabolic stress and autophagy in diabetes
- (2012) Kimberley M Mellor et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Rapamycin Reduces Reactive Oxygen Species in Cultured Human Corneal Endothelial Cells
- (2012) Young Joo Shin et al. CURRENT EYE RESEARCH
- Rapamycin protects against myocardial ischemia–reperfusion injury through JAK2–STAT3 signaling pathway
- (2012) Anindita Das et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A unifying model for mTORC1-mediated regulation of mRNA translation
- (2012) Carson C. Thoreen et al. NATURE
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Macrovascular Effects and Safety Issues of Therapies for Type 2 Diabetes
- (2011) Jorge Plutzky AMERICAN JOURNAL OF CARDIOLOGY
- Rapamycin inhibits hydrogen peroxide-induced loss of vascular contractility
- (2011) Ge Gao et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Autophagy anomalies in the diabetic myocardium
- (2011) Kimberley M. Mellor et al. Autophagy
- Proteomic analysis of mitochondrial proteins in a mouse model of type 2 diabetes
- (2011) M.F. Essop et al. Cardiovascular Journal of Africa
- Oxidative stress and diabetes mellitus
- (2011) Hui Yang et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials
- (2011) Antoinette de Waha et al. Clinical Research in Cardiology
- Absence of altered autophagy after myocardial ischemia in diabetic compared with nondiabetic mice
- (2011) Christopher J. French et al. CORONARY ARTERY DISEASE
- Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+signalling in young type 2 Zucker diabetic fatty rat heart
- (2011) F. C. Howarth et al. EXPERIMENTAL PHYSIOLOGY
- Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response
- (2011) Kari T. Chambers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity
- (2011) Lei Xi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice
- (2011) Kimberley M. Mellor et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction
- (2011) Miranda M. Y. Sung et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol
- (2011) Angana G. Rajapakse et al. PLoS One
- The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile
- (2011) B. T. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle
- (2010) Joshua C. Drake et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction
- (2010) Subat Turdi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Nebulette Mutations Are Associated With Dilated Cardiomyopathy and Endocardial Fibroelastosis
- (2010) Enkhsaikhan Purevjav et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance
- (2010) S. C. Ranieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin inhibits mTORC1, but not completely
- (2009) Carson C. Thoreen et al. Autophagy
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
- (2009) Hiroyuki Mori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice
- (2009) Nicolas Vignier et al. CIRCULATION RESEARCH
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the mTOR Signaling Network for Cancer Therapy
- (2009) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes
- (2008) Shigemiki Omiya et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started